Coloplast As Sp/Adr (CLPBY) Q3 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, welcome to the Coloplast Interim Financial Statement for 9 months 2025-26 conference call. And I'm Moritz, the conference call operator. I would like to remind you that all participants will be in a listen-only mode and the conference is being recorded. The presentation will be followed by a question and answer session. You can register for questions at any time by pressing star and 1 on your telephone. For operator assistance, please press star and zero. The conference must not be recorded for publication or broadcast. At this time, it's our pleasure to hand over to Gavin Wood, Income President and CEO. Please go ahead, sir. Good morning, everyone, and welcome to Coloplast Q3 2025-26 conference call. I'm Gavin Wood, President and CEO of Coloplast. I'm joined today by our CFO Anders and our investor relations team, Anders and I will take you through the quarter and then we'll open up the call for questions. Please turn to slide number three. Over my first hundred days at Coloplast, I've spent a great deal of time with our businesses, customers, users, and colleagues. When we last met, I spoke about what attracted me to Coloplast, its purpose, its people, and its ambition. What I've seen since joining has reinforced that initial view. Coloplast is fundamentally a strong company. We operate in attractive markets, hold leadership positions across our businesses, and continue to generate sustainable growth, profitability, and cash flow. The Impact4 strategy provides a strong foundation. As we progress through the rest of the year, I will continue to evaluate our priorities and the choices that will be critical to driving growth and long-term value creation. Today, I want to highlight a few. Starting with the core of Coloplast, chronic care. We have ...